Escitalopram in Schizophrenia in OCD- Open Label Study

BeerYaakov Mental Health Center15 enrolled

Overview

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Masking

NONE

Enrollment

Conditions

Schizophrenia

Interventions

EscitalopramDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who suffer from schizophrenia and OCD Exclusion Criteria: * Substance abuse, * Serious medical condintions, * Being on SSRI treatment

Locations (1)

Beer Yaakov MHC

Beer Yaakov, Israel

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.